Pluristem Therapeutics receives key 3D cell expansion patent in Australia
moreView todays social media effects on PSTIView the latest stocks trending across Twitter. Click to view dashboardSee who Pluristem is hiring next, click here to view […]
PSTI
Pluristem Receives Key 3D Cell Expansion Patent in Australia
[GlobeNewswire] – HAIFA, Israel — Pluristem Therapeutics, Inc. , a leading developer of placenta-based cell therapies, today announced it has been granted a new patent by the Australian Patent Office. Patent #2007228341 … moreView todays social media effects on PSTIView the latest stocks trending across Twitter. Click to view dashboardSee who Pluristem is hiring next, click here to view […]
Pluristem CEO Zami Aberman to Speak on Panel at 9th Annual Stem Cell Summit on February 18, 2014
[GlobeNewswire] – HAIFA, Israel — Pluristem Therapeutics, Inc. , a leading developer of placenta-based cell therapies, today announced that its CEO and Chairman, Zami Aberman, will be a speaker on a panel titled, Disrupting … moreView todays social media effects on PSTIView the latest stocks trending across Twitter. Click to view dashboardSee who Pluristem is hiring next, click here to […]
PLURISTEM THERAPEUTICS INC Financials
moreView todays social media effects on PSTIView the latest stocks trending across Twitter. Click to view dashboardSee who Pluristem is hiring next, click here to view […]
Medical Key Opinion Leaders in Preeclampsia Join Pluristem’s Steering Committee
[GlobeNewswire] – HAIFA, Israel — Pluristem Therapeutics, Inc. , a leading developer of placenta-based cell therapies, today announced it has formed a Preeclampsia Steering Committee to advance its PLacental eXpanded (PLX) … moreView todays social media effects on PSTIView the latest stocks trending across Twitter. Click to view dashboardSee who Pluristem is hiring next, click here to view […]
Pluristem Receives FDA Orphan Drug Status Designation for Treatment of Aplastic Anemia
[at noodls] – HAIFA, Israel February 21, 2013 – Pluristem Therapeutics Inc. (NASDAQCM: PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapies, announced today that the U.S. Food and Drug Administration … moreView todays social media effects on PSTIView the latest stocks trending across Twitter. Click to view dashboardSee who Pluristem is hiring next, click here to view […]
Pluristem Takes Possession of and Moving Into New State-of-the-Art Manufacturing Facility
[at noodls] – HAIFA, ISRAEL, January 30, 2013- Pluristem Therapeutics, Inc.(NASDAQCM:PSTI; TASE:PLTR), a leading developer of placenta-based cell therapies, announced today that the company has taken possession of and … moreView todays social media effects on PSTIView the latest stocks trending across Twitter. Click to view dashboardSee who Pluristem is hiring next, click here to view […]
Pluristem’s CEO Letter to Shareholders
[at noodls] – Pluristem’s CEO Letter to Shareholders Dear Pluristem Shareholders, In 2012 we have made great progress and moved closer to fulfilling our vision of being a leader in developing and manufacturing cell … moreView todays social media effects on PSTIView the latest stocks trending across Twitter. Click to view dashboardSee who Pluristem is hiring next, click here to […]
Pluristem Initiates Final Validation of New Manufacturing Facility
[at noodls] – HAIFA, ISRAEL, December 27, 2012- Pluristem Therapeutics, Inc.(NASDAQCM: PSTI; TASE:PLTR), a leading developer of placenta-based cell therapies, announced today it has initiated the final validation steps … moreView todays social media effects on PSTIView the latest stocks trending across Twitter. Click to view dashboardSee who Pluristem is hiring next, click here to view […]
Pluristem to Present at Oppenheimer 23rd Annual Healthcare Conference
[at noodls] – HAIFA, ISRAEL, December 12, 2012 — Pluristem Therapeutics, Inc. (NASDAQCM:PSTI; TASE:PLTR) today announced that William R. Prather RPh, MD, Senior VP Corporate Development, will present at the Oppenheimer … moreView todays social media effects on PSTIView the latest stocks trending across Twitter. Click to view dashboardSee who Pluristem is hiring next, click here to view […]
